CAF-mediated resistance to targeted therapy in solid tumors can be categorized into (1) specific resistance to hormone-receptor-targeted anti-cancer drugs and (2) specific resistance to non-hormonal pathway-targeted anti-cancer drugs (Figure 2). The gene discussed is NR4A1; the disease is cancer.